Wells Fargo & Company Meira G Tx Holdings PLC Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MGTX
# of Institutions
100Shares Held
45.4MCall Options Held
19.2KPut Options Held
31K-
Perceptive Advisors LLC New York, NY12.6MShares$80.4 Million1.37% of portfolio
-
Johnson & Johnson New Brunswick, NJ6.64MShares$42.4 Million8.83% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.23MShares$33.4 Million0.04% of portfolio
-
Prosight Management, LP Dallas, TX4.9MShares$31.3 Million5.49% of portfolio
-
683 Capital Management, LLC New York, NY2.55MShares$16.3 Million0.97% of portfolio
About MeiraGTx Holdings plc
- Ticker MGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,010,700
- Market Cap $288M
- Description
- MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...